Pulmonary hypertension associated with congenital diaphragmatic hernia

Cardiology in the Young

Volumn 19, Issue E-SUPP. 1, 2009, Pages 49-53

  Thébaud, Bernard ^a   Tibboel, Dick ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Congenital heart disease; Neonatal intensive care; Neonatal pulmonary hypertension; Persistent pulmonary hypertension of the newborn

Indexed keywords

NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN;

ARTICLE; CONGENITAL DIAPHRAGM HERNIA; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART CATHETERIZATION; HEART EJECTION FRACTION; HUMAN; LUNG CIRCULATION; LUNG VOLUME; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGEN THERAPY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL RATE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; DIAPHRAGM HERNIA; FETUS ECHOGRAPHY; NEWBORN;

HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; ULTRASONOGRAPHY, PRENATAL;

EID: 68949208474     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109003965     Document Type: Article

References (36)

1. Mohseni-Bod H, Bohn D. Pulmonary hypertension in congenital diaphragmatic hernia. Semin Pediatr Surg 2007; 16: 126-133.
2. Thebaud B, Mercier JC, Dinh-Xuan AT. Congenital diaphragmatic hernia. A cause of persistent pulmonary hypertension of the newborn which lacks an effective therapy. Biol Neonate 1998; 74: 323-336.
3. Langham MR, Jr., Kays DW, Ledbetter DJ, et al. Congenital diaphragmatic hernia. Epidemiology and outcome. Clin Perinatol 1996; 23: 671-688.
4. Bohn D. Congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002; 166: 911-915.
5. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597-604.
6. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2001(4): CD000399.
7. Field DJ, Pearson GA. Neonatal extra corporeal membrane oxygenation (ECMO). J Perinat Med 1994; 22: 565-569.
8. Peek GJ, Sosnowski AW. Extra-corporeal membrane oxygenation for paediatric respiratory failure. Br Med Bull 1997; 53: 745-756.
9. Logan JW, Rice HE, Goldberg RN, et al. Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies. J Perinatol 2007; 27: 535-549.
10. Bagolan P, Morini F. Long-term follow up of infants with congenital diaphragmatic hernia. Semin Pediatr Surg 2007; 16: 134-144.
11. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: Acute, late, and chronic pulmonary hypertension. Semin Perinatol 2005; 29: 123-128.
12. Muratore CS, Kharasch V, Lund DP, et al. Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic. J Pediatr Surg 2001; 36: 133-140.
13. Stiller RJ, Roberts NS,Weiner S, et al. Congenital diaphragmatic hernia: antenatal diagnosis and obstetrical management. J Clin Ultrasound 1985; 13: 212-215.
14. Keller RL. Antenatal and postnatal lung and vascular anatomic and functional studies in congenital diaphragmatic hernia: Implications for clinical management. Am J Med Genet C Semin Med Genet 2007; 145: 184-200.
15. Schwartz SM, Vermilion RP, Hirschl RB. Evaluation of left ventricular mass in children with left-sided congenital diaphragmatic hernia. J Pediatr 1994; 125: 447-451.
16. Siebert JR, Haas JE, Beckwith JB. Left ventricular hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg 1984; 19: 567-571.
17. Thebaud B, Azancot A, de Lagausie P, et al. Congenital diaphragmatic hernia: Antenatal prognostic factors. Does cardiac ventricular disproportion in utero predict outcome and pulmonary hypoplasia? Intensive Care Med 1997; 23: 10062-10069.
18. Jani J, Keller RL, Benachi A, et al. Prenatal prediction of survival in isolated left-sided diaphragmatic hernia. Ultrasound Obstet Gynecol 2006; 27: 18-22.
19. Ba'ath ME, Jesudason EC, Losty PD. How useful is the lung-to-head ratio in predicting outcome in the fetus with congenital diaphragmatic hernia? A systematic review and meta-analysis. Ultrasound Obstet Gynecol 2007; 30: 897-906.
20. Coakley FV, Lopoo JB, Lu Y, et al. Normal and hypoplastic fetal lungs: volumetric assessment with prenatal single-shot rapid acquisition with relaxation enhancement MR imaging. Radiology 2000; 216: 107-111.
21. Rypens F, Metens T, Rocourt N, et al. Fetal lung volume: Estimation at MR imaging-initial results. Radiology 2001; 219: 236-241.
22. Mahieu-Caputo D, Sonigo P, Dommergues M, et al. Fetal lung volume measurement by magnetic resonance imaging in congenital diaphragmatic hernia. Bjog 2001; 108: 863-868.
23. Peralta CF, Kazan-Tannus JF, Bunduki V, et al. Evaluation of the agreement between 3-dimensional ultrasonography and magnetic resonance imaging for fetal lung volume measurement. J Ultrasound Med 2006; 25: 461-467.
24. Ruano R, Martinovic J, Dommergues M, et al. Accuracy of fetal lung volume assessed by three-dimensional sonography. Ultrasound Obstet Gynecol 2005; 26: 725-730.
25. Dillon PW, Cilley RE, Mauger D, et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 307-312; discussion 307-312.
26. Cohen MS, Rychik J, Bush DM, et al. Influence of congenital heart disease on survival in children with congenital diaphragmatic hernia. J Pediatr 2002; 141: 25-30.
27. Davis PJ, Firmin RK, Manktelow B, et al. Long-term outcome following extracorporeal membrane oxygenation for congenital diaphragmatic hernia: the UK experience. J Pediatr 2004; 144: 309-315.
28. Miniati D. Pulmonary vascular remodeling. Semin Pediatr Surg 2007; 16: 80-87.
29. Buysse C, Fonteyne C, Dessy H, et al. The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 2001; 36: 1864-1865.
30. Kinsella JP, Torielli F, Ziegler JW, et al. Dipyridamole augmentation of response to nitric oxide. Lancet 1995; 346 (8975): 647-648.
31. Thebaud B, Saizou C, Farnoux C, et al. Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. Intensive Care Med 1999; 25: 300-303.
32. Filan PM, McDougall PN, Shekerdemian LS. Combination pharmacotherapy for severe neonatal pulmonary hypertension. J Paediatr Child Health 2006; 42: 219-220.
33. Keller RL, Hamrick SE, Kitterman JA, et al. Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia. Pediatr Crit Care Med 2004; 5: 184-187.
34. Keller RL, Moore P, Teitel D, et al. Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy. Pediatr Crit Care Med 2006; 7: 589-594.
35. Noori S, Friedlich P,Wong P, et al. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 2007; 91: 92-100.
36. Kinsella JP, Parker TA, Ivy DD, et al. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr 2003; 142: 397-401.